Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (61-70 of 382) with videos related to

Pageof 39
Sort By:
International Journal of Cardiology|August 9, 2006
The role of intravenous immunoglobulin in the treatment of chronic heart failurePål Aukrust, Arne Yndestad, Thor Ueland, et al.
Autoimmunity|December 29, 2004
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibodyLisa Larsson, Reza Mobini, Pål Aukrust, et al.
Open Heart|December 12, 2017
Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipientsMarianne Yardley, Thor Ueland, Pål Aukrust, et al.
Clinical Transplantation|November 20, 2016
Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trialMarianne Yardley, Lars Gullestad, Bjørn Bendz, et al.
Current Heart Failure Reports|January 31, 2014
Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failureErik Tandberg Askevold, Lars Gullestad, Christen P Dahl, et al.
Clinical Cardiology|July 29, 2011
No impact of atrial fibrillation on mortality risk in optimally treated heart failure patientsArnljot Tveit, Berit Flonaes, Ellinor Aaser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 10, 2014
Inflammatory cytokines as biomarkers in heart failureThor Ueland, Lars Gullestad, Ståle H Nymo, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|April 28, 2012
The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarctionGunnar Erikssen, Knut Liestøl, Lars Gullestad, et al.
Circulation. Heart Failure|February 9, 2022
Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic StudyAnette B Kvaslerud, Einar Gude, Gunnar Eriksen, et al.
International Journal of Cardiology|June 7, 2011
Galectin-3 in heart failure: high levels are associated with all-cause mortalityThor Ueland, Pål Aukrust, Kaspar Broch, et al.
Pageof 39

Showing results (61-70 of 382) with videos related to

Sort By:
Pageof 39
International Journal of Cardiology|August 9, 2006
The role of intravenous immunoglobulin in the treatment of chronic heart failurePål Aukrust, Arne Yndestad, Thor Ueland, et al.
Autoimmunity|December 29, 2004
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibodyLisa Larsson, Reza Mobini, Pål Aukrust, et al.
Open Heart|December 12, 2017
Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipientsMarianne Yardley, Thor Ueland, Pål Aukrust, et al.
Clinical Transplantation|November 20, 2016
Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trialMarianne Yardley, Lars Gullestad, Bjørn Bendz, et al.
Current Heart Failure Reports|January 31, 2014
Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failureErik Tandberg Askevold, Lars Gullestad, Christen P Dahl, et al.
Clinical Cardiology|July 29, 2011
No impact of atrial fibrillation on mortality risk in optimally treated heart failure patientsArnljot Tveit, Berit Flonaes, Ellinor Aaser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 10, 2014
Inflammatory cytokines as biomarkers in heart failureThor Ueland, Lars Gullestad, Ståle H Nymo, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|April 28, 2012
The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarctionGunnar Erikssen, Knut Liestøl, Lars Gullestad, et al.
Circulation. Heart Failure|February 9, 2022
Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic StudyAnette B Kvaslerud, Einar Gude, Gunnar Eriksen, et al.
International Journal of Cardiology|June 7, 2011
Galectin-3 in heart failure: high levels are associated with all-cause mortalityThor Ueland, Pål Aukrust, Kaspar Broch, et al.
Pageof 39